$VSTM Cashflow Statement | Understand Stock

$VSTM

$10.10 +$0.10 (1.0%) Close

$VSTM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Operating activities
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Amortization of acquired intangible assets
Non-cash operating lease cost
Stock-based compensation expense
Amortization of deferred financing costs, debt discounts and premiums and discounts on available-for-sale marketable securities
Change in fair value of preferred stock tranche liability
Change in fair value of warrant liability
Non-cash change in fair value of Notes
Loss on debt extinguishment
Changes in operating assets and liabilities:
Accounts receivable, net
Grant receivable
Inventory
Prepaid expenses, other current assets and other assets
Accounts payable
Accrued expenses and other liabilities
Deferred liabilities
Net cash used in operating activities
Investing activities
Purchases of property and equipment
Purchases of intangible assets
Purchases of investments
Maturities of investments
Net cash (used in) provided by investing activities
Financing activities
Proceeds from the issuance of common stock and pre-funded warrants, net
Proceeds from the issuance of warrants
Proceeds from issuance of Series B Convertible Preferred Stock, net
Proceeds from exercise of warrants
Proceeds from long-term debt
Repayment of long-term debt
Payments for loan amendment
Repayment of 2018 Notes
Proceeds from insurance premium financing
Payments on insurance premium financing
Proceeds from the exercise of stock options and employee stock purchase program
Settlement of restricted stock for tax withholdings
Net cash provided by financing activities

Increase in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Supplemental disclosure
Cash paid for interest
Cash paid for income tax expense
Supplemental disclosure of non-cash investing and financing activities
Issuance of preferred stock tranche liability
Conversion of 2020 Notes into common stock
5.00% Convertible Senior Third Lien Notes due 2048
Total conversion of 2020 Notes into common stock
Purchases of property and equipment included in accounts payable and accrued expenses
Issuance costs included in accounts payable and accrued expenses
Conversion of Series B Convertible Preferred Stock to common stock
Conversion of warrant liability into additional paid-in capital upon warrant exercise
Right of use asset obtained in exchange for operating lease liability
Purchases of intangible asset in accounts payable and accrued expenses

Comments